Merck (MRK) Return on Invested Capital (2009 - 2026)

Merck (MRK) has reported Return on Invested Capital for 18 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Invested Capital eased to 0.01% in Q1 2026 per MRK's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q3 2025 and bottomed at 0.01% in Q1 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• Annual changes were most pronounced in 2022 — Return on Invested Capital rose 1 bps — and 2023, when it decreased 1 bps.
• Merck's Return on Invested Capital stood at 0.0% in 2022, then slumped by 243 bps to 0.0% in 2023, then jumped by 202 bps to 0.0% in 2024, then jumped by 65 bps to 0.01% in 2025, then tumbled by 197 bps to 0.01% in 2026.
• Business Quant data shows MRK's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.